Company Filing History:
Years Active: 2007-2009
Title: Mahesh C Sharma: Innovator in Angiogenesis Inhibition
Introduction
Mahesh C Sharma is a notable inventor based in Turnersville, NJ (US). He has made significant contributions to the field of medical research, particularly in the area of angiogenesis inhibition. With a total of 2 patents, his work focuses on developing methods and compositions that can effectively treat diseases characterized by unwanted angiogenesis.
Latest Patents
Mahesh's latest patents include innovative methods for inhibiting angiogenesis in endothelial cells. These methods involve selectively inducing apoptosis in endothelial cells through compounds that bind to annexin II. The compounds and methods he has developed are particularly useful in treating various diseases or disorders associated with unwanted angiogenesis. Additionally, he has provided pharmaceutical compositions that contain these compounds along with a pharmaceutically acceptable vehicle, as well as methods for identifying such compounds.
Career Highlights
Mahesh C Sharma is affiliated with the Philadelphia Health and Education Corporation, where he continues to advance his research and innovations. His work has garnered attention for its potential applications in therapeutic settings, particularly in oncology and other fields where angiogenesis plays a critical role.
Collaborations
One of his notable collaborators is George P Tuszynski, with whom he has worked on various projects related to his patents and research initiatives.
Conclusion
Mahesh C Sharma's contributions to the field of angiogenesis inhibition highlight his innovative spirit and dedication to improving medical treatments. His patents represent significant advancements that could lead to better therapeutic options for patients suffering from diseases characterized by unwanted angiogenesis.